Innovative mobile technologies are continuously being introduced, and savvy life sciences organizations are taking note. Many of these technologies have the potential to drastically reduce the time and cost of clinical trials, from subject recruitment to data collection, not to mention likely create a boost in patient engagement. In our webinar, Perficient’s director of clinical operations solutions, Param Singh, explored the opportunities and challenges some of these new and emerging technologies present for the life sciences industry. Topics included wearable devices, biosensors, mobile phones, integrations with clinical and safety systems, and patient-driven clinical research.

1. Incorporating Digital Technology
into Clinical Trials
October 2016

2. 2
About Perficient
Perficient is the leading digital transformation
consulting firm serving Global 2000 and enterprise
customers throughout North America.
With unparalleled information technology, management consulting,
and creative capabilities, Perficient and its Perficient Digital agency
deliver vision, execution, and value with outstanding digital
experience, business optimization, and industry solutions.

3. 3
Perficient Profile
Founded in 1997
Public, NASDAQ: PRFT
2015 revenue $473.6 million
Major market locations:
Allentown, Atlanta, Ann Arbor, Boston, Charlotte,
Chattanooga, Chicago, Cincinnati, Columbus, Dallas,
Denver, Detroit, Fairfax, Houston, Indianapolis, Lafayette,
Milwaukee, Minneapolis, New York City, Northern California,
Oxford (UK), Southern California, St. Louis, Toronto
Global delivery centers in China and India
3,000+ colleagues
Dedicated solution practices
~95% repeat business rate
Alliance partnerships with major technology vendors
Multiple vendor/industry technology and growth awards

4. Param Singh
Director, Clinical Operations Solutions

5. 5
• Life sciences is going digital
• Subject recruitment
• Subject screening
• Informed consent
• Clinical data collection
• Post-market / real-world data
• Q&A
• Next steps
Agenda

6. 6
• Acute care  Preventive care
• Specialists  Self-care
• Hospitals  Home care
• Single biometric indicators  Multiple indicators
• Empirical evidence for “typical” patients 
Personalized, precision medicine
• Specialized information silos 
Centralized, accessible knowledge centers
Bottom Line: Life sciences needs to understand,
harness, and capitalize on these shifts (i.e., we need to
“go digital”)
Healthcare Shifts

7. 7
“The mClinical team is redefining when, where and how patients engage in
clinical research through innovative digital and mobile solutions to support
communications and data collection for recruitment, screening, electronic
consent, study participation retention and compliance, and patient reported
outcomes.”
Seth Schulman, Head of Clinical Excellence and Innovation, Pfizer

8. 8
Subject Recruitment

9. 9
Subject Screening

10. 10
Informed Consent

11. 11
Clinical Data Collection

12. 12
Post-Market / Real-World Data

13. Questions
Type your question into the chat box

14. 14
• Mining Online Communities and Social Networks
for Safety Signals | register
November 17, 2016
• How to Review, Cleanse, and Transform Clinical
Data in Oracle InForm | register
December 8, 2016
Follow Us Online
• Perficient.com/SocialMedia
• Facebook.com/Perficient
• Twitter.com/Perficient_LS
• Blogs.perficient.com/LifeSciences

15. Thank You